www.alphatau.com Open in urlscan Pro
151.101.1.84  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 
Skip to Main Content


Treating Cancer With Precision

 * Home

 * Alpha DaRT

 * Treatment

 * Clinical Trials
   
   * All Clinical Trials
   * Skin Cancer
   * Oral Cavity Cancer
   * Self-Assessment Form
   * Preclinical Trials

 * Publications
   
   * Clinical Publications
   * Pre-Clinical Pubications
   * Scientific Posters

 * About
   
   * About Alpha Tau
   * News & Blog
   * Careers
   * Management
   * Scientific Advisory Board
   * Board of Directors
   * Contact

 * Investors
   
   * Stock Information
   * SEC Filings
   * Events & Presentation
   * Corporate Governance

 * More


Use tab to navigate through the menu items.

Subscribe to our newsletter


Highly Potent and Conformal Alpha Emitters Radiotherapy for the Treatment of
Solid Cancer Tumors

READ MORE



THE ALPHA DART TREATMENT

 

Alpha DaRT enables a highly potent and conformal radiation treatment for solid
cancer tumors. Directly inserted into the tumor, the Alpha DaRT sources release
a high-energy dose over a range of several millimeters enabling a focal
alpha-radiation treatment that spares the surrounding healthy tissue. The Alpha
DaRT treatment has several significant clinical advantages…

READ MORE

The Alpha DaRT Technology

 

The Alpha DaRT breakthrough technology utilizes Alpha radiation to treat cancer.
DaRT (Diffusing Alpha-emitters Radiation Therapy) treats solid tumors with
interstitial radioactive sources that continually release short-lived
alpha-emitting atoms into the tumor.

READ MORE



Alpha DaRT Clinical Trials

 

Alpha Tau Medical is currently running clinical trials for:

- Skin Cancer
- Oral Cavity Cancer

- Breast Cancer

The company is working with leading cancer researchers to commence additional
trials for further indications.

READ MORE


ABOUT ALPHA TAU MEDICAL
 

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing
Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The
Alpha DaRT technology was developed in 2003 at Tel Aviv University.

 

 


CONTACT US


 * Home

 * Alpha DaRT

 * Treatment

 * Clinical Trials
   
   * All Clinical Trials
   * Skin Cancer
   * Oral Cavity Cancer
   * Self-Assessment Form
   * Preclinical Trials

 * Publications
   
   * Clinical Publications
   * Pre-Clinical Pubications
   * Scientific Posters

 * About
   
   * About Alpha Tau
   * News & Blog
   * Careers
   * Management
   * Scientific Advisory Board
   * Board of Directors
   * Contact

 * Investors
   
   * Stock Information
   * SEC Filings
   * Events & Presentation
   * Corporate Governance

 * More


Use tab to navigate through the menu items.

Looking for clinical trials?

See if you're eligible
Newsletter
 * 
 * 
 * 
 * 


PRIVACY POLICY

CONTACT US

This site or third-party tools used by this make use of cookies necessary for
its operation and useful for the purposes described in the cookie policy . If
you want to know more, consult the cookie policy. By closing this banner, or
continuing to browse, you consent to the use of cookies.

I agree